# FDA Inspection 1256167 - Biomat USA, Inc. - November 15, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/e6fbb6d9-ebe5-4f21-84f7-88ad38ebb968
Source feed: FDA_Inspections

> FDA Inspection 1256167 for Biomat USA, Inc. on November 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256167
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256167 - 2024-11-15](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/b8fad5ec-c419-495f-a410-760033a00a06)
- [FDA Inspection 1026545 - 2017-09-22](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/30d5dfec-bd2a-44b3-9a14-b189f1d51c5e)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/050c35c8-a2e3-4c1d-a3c4-15168f2b297c

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d